U.S. Markets open in 4 hrs 18 mins

Alkame Launches HydrO2Pet(TM) -- The Ultimate Health & Wellness Water(R) Product Line for Pets

LAS VEGAS, NV--(Marketwired - Feb 22, 2016) - Alkame Holdings, Inc. ( OTC : ALKM ), a publicly traded health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly products, is pleased to announce a new division called Alkame Pets, and is launching its new line of water based pet products called HydrO²Pet™.

The Company's patented technology electrically changes the molecular structure of normal water producing 4 important characteristics, which are potent electrolytes and antioxidants, elevated pH levels to create a mildly alkaline water, elevated dissolved oxygen, and a reduced molecular structure for optimal hydration, free from chlorine, fluoride, and heavy metals. These advanced and synergistic properties enable simple one step solutions for consumers to provide The Ultimate Health & Wellness Water® for their pets. 

The HydrO²Pet™ lineup of pet products initially include SKUs developed for cats, dogs, and assorted small animals such as rabbits, gerbils, hamsters and guinea pigs. Product sizes range from 16oz to 2.5 gallon containers. Aquatic products for fish, reptiles and birds, while still in beta phase, should be introduced into the new lineup of pet products in the very near future. 

Alkame Pet's main focus is to build a strong foundation and grow a retail footprint that will include pet distributors and pet retailers, as well as mass merchandisers, hardware, grocery, veterinary, shelters and hospitals. The new HydrO²Pet™ product line is being represented by the well-respected national independent pet sales organization SLA Brands, one of the country's top pet sales groups.

According to Robert Eakle, CEO of Alkame Holdings, Inc., "We are very pleased to be presenting and introducing this new line of pet products, utilizing our patented water treatment technology to our extended families we call 'our pets.' The response to our new line has been extremely positive, and it's exciting to show the world another great application and use for our patented technology."

About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties, enabling an increase to available oxygen content, optimized pH levels, as well as the added benefits of electrolytes, and enhancement of antioxidant properties, equating into many potential health benefits, such as a reduced structure for permeability, improved metabolic efficiency, a boosted immune system, improved cardio respiratory function, and a decrease in lactic acid for faster muscle recovery. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com or www.hydro2pet.com.

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.